David P. Kirchhoff
Analyst
Let me first take a note, which is I think probably what would be a good idea for us to do is actually to go back and think through what might be some way to dimensionalize the opportunity so that we could share that with the investment community on a go-forward basis. And we typically provide a couple names just to give color, but obviously, we've brought in more than 2 accounts. In fact, it was a number. If you look, though, at places where -- sections of the economy where we've been having particularly good early progress, some of the ones that come to mind, first and foremost, have been frankly, health-based companies. So that's health systems, hospital networks, those types of organizations, as well, for example, health insurance companies, pharma companies, others, all on behalf of their employees. And that's been particularly important for us in a number of different dimensions. First off, it's good business. These are nice accounts for us to bring in. Secondly, it is allowing us to begin building an ongoing working relationship with some of the nation's leading health companies that we're going to look to leverage as we go into future years as we continue to build out our healthcare strategy. And so I think -- so that -- hopefully, that gives you a little bit of flavor. And we've also been making good progress with municipalities. And then it's been -- cities. Then it's been sort of a hodgepodge kind of across various industries, retail, manufacturing, back offices, call centers, things like that.
Jerry R. Herman - Stifel, Nicolaus & Co., Inc., Research Division: Okay, great. And then you talked about compensation to the leaders, and I guess I interpreted those comments as you're going to pay more money. And I guess, a two-part question. Number one is, does that reflect some competitiveness in the market for those individuals? And number two, is it also contemplated in the gross margin in the guidance you guys gave?